2025
SJR Q4
JCR Q2 · 1,4
OA
2 matched articles
Journal detail
Antiviral Chemistry and Chemotherapy
- Publisher
- SAGE Publications Inc.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0956320220402066
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,23
- Quartile Q4
- H-Index 62
- Cites/doc 1,5
- Docs (3y) 8
- Cites (3y) 7
Clarivate
Web of Science · JCR · 2001
- JCR Q Q2
- JIF 1,4
- 5Y JIF —
- JCI —
Subject classification
Categories (SJR)
- Drug Discovery Q4
- Medicine (miscellaneous) Q4
- Pharmacology Q4
- Virology Q4
Areas
- Immunology and Microbiology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q4 | — | 0,23 | — | — | — | — | 62 |
| 2024 | Q3 | — | 0,325 | — | — | — | — | 61 |
| 2023 | Q3 | — | 0,369 | — | — | — | — | 61 |
| 2022 | Q2 | — | 0,518 | — | — | — | — | 61 |
| 2021 | Q1 | — | 0,844 | — | — | — | — | 61 |
| 2020 | Q1 | — | 0,919 | — | — | — | — | 61 |
| 2019 | Q2 | — | 0,597 | — | — | — | — | 61 |
| 2017 | Q2 | — | 0,635 | — | — | — | — | 61 |
| 2016 | Q3 | — | 0,387 | — | — | — | — | 61 |
| 2015 | Q2 | — | 0,621 | — | — | — | — | 61 |
| 2014 | Q2 | — | 0,677 | — | — | — | — | 61 |
| 2013 | Q2 | — | 0,801 | — | — | — | — | 61 |
| 2012 | Q2 | — | 0,734 | — | — | — | — | 61 |
| 2011 | Q1 | — | 0,811 | — | — | — | — | 61 |
| 2010 | Q2 | — | 0,59 | — | — | — | — | 61 |
| 2001 | — | Q2 | — | 1,4 | — | — | — | — |
| 2000 | — | Q1 | — | 2,4 | — | — | — | — |
| 1999 | — | Q2 | — | 1,8 | — | — | — | — |
| 1998 | — | Q2 | — | 1,7 | — | — | — | — |
| 1997 | — | Q2 | — | 1,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 193/308 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 90/186 |
| 2001 | VIROLOGY | SCIE | Q4 | — | 20/25 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 123/310 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 40/181 |
| 2000 | VIROLOGY | SCIE | Q2 | — | 13/28 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 143/295 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 53/175 |
| 1999 | VIROLOGY | SCIE | Q2 | — | 13/26 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 143/295 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 52/178 |
| 1998 | VIROLOGY | SCIE | Q2 | — | 12/25 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 133/253 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 52/157 |
| 1997 | VIROLOGY | SCIE | Q3 | — | 15/24 |